Yugang Wang

813 total citations
19 papers, 386 citations indexed

About

Yugang Wang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Yugang Wang has authored 19 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Yugang Wang's work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Yugang Wang is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Yugang Wang collaborates with scholars based in United States, China and South Korea. Yugang Wang's co-authors include Todd M. Morgan, Jae‐Seung Chung, Kenneth J. Pienta, Russell S. Taichman, Evan T. Keller, Jacques E. Nör, Lonnie D. Shea, Ganesh S. Palapattu, Laurie K. McCauley and Yuanyuan Qiao and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Yugang Wang

16 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yugang Wang United States 10 157 142 132 103 89 19 386
Mingtian Wei China 14 186 1.2× 77 0.5× 319 2.4× 170 1.7× 53 0.6× 42 608
Da‐Lei Zhou China 11 122 0.8× 49 0.3× 153 1.2× 89 0.9× 66 0.7× 24 352
He-Li Gao China 9 312 2.0× 97 0.7× 207 1.6× 171 1.7× 71 0.8× 10 526
Haifeng Wang China 10 53 0.3× 127 0.9× 153 1.2× 62 0.6× 43 0.5× 43 357
Yuchao Dong China 11 87 0.6× 110 0.8× 177 1.3× 88 0.9× 51 0.6× 27 405
Yixiao Xiong China 12 62 0.4× 112 0.8× 233 1.8× 144 1.4× 49 0.6× 20 405
Rongkun Li China 15 111 0.7× 99 0.7× 420 3.2× 260 2.5× 99 1.1× 25 589
Xuyu Gu China 11 117 0.7× 79 0.6× 225 1.7× 158 1.5× 59 0.7× 37 444
Peifen Fu China 9 214 1.4× 45 0.3× 135 1.0× 97 0.9× 93 1.0× 19 390

Countries citing papers authored by Yugang Wang

Since Specialization
Citations

This map shows the geographic impact of Yugang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yugang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yugang Wang more than expected).

Fields of papers citing papers by Yugang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yugang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yugang Wang. The network helps show where Yugang Wang may publish in the future.

Co-authorship network of co-authors of Yugang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yugang Wang. A scholar is included among the top collaborators of Yugang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yugang Wang. Yugang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Shi, R., Qiong Wu, Jinlu Han, et al.. (2025). Biomineralized Cu-Disulfiram nanoparticles Potentiate Colorectal cancer immunotherapy through synergistic cuproptosis and apoptosis. Materials & Design. 260. 115070–115070.
2.
Wang, Yugang, et al.. (2024). Clinical predictors of prognosis in stroke patients after endovascular therapy. Scientific Reports. 14(1). 667–667. 5 indexed citations
3.
Wang, Yugang, et al.. (2023). Relationship between cognitive dysfunction and the promoter methylation of PER1 and CRY1 in patients with cerebral small vessel disease. Frontiers in Aging Neuroscience. 15. 1174541–1174541. 5 indexed citations
4.
Wang, Yugang, et al.. (2023). Clinical characteristics of cerebral venous sinus thrombosis patients with new-onset of headache. BMC Neurology. 23(1). 56–56. 3 indexed citations
5.
Wang, Yugang, Yi Zhong, Xiang Xu, et al.. (2022). Axin1 participates in blood–brain barrier protection during experimental ischemic stroke via phosphorylation at Thr485 in rats. Journal of Chemical Neuroanatomy. 127. 102204–102204. 4 indexed citations
6.
Reichert, Zachery R., Tadas Kasputis, Yugang Wang, et al.. (2021). Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). International Journal of Molecular Sciences. 23(1). 4–4. 8 indexed citations
7.
Wang, Yugang, Udit Singhal, Yuanyuan Qiao, et al.. (2020). Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion. Translational Oncology. 13(4). 100747–100747. 37 indexed citations
8.
Chung, Jae‐Seung, Yugang Wang, James Henderson, et al.. (2019). Circulating Tumor Cell–Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer. Neoplasia. 21(8). 802–809. 27 indexed citations
9.
Singhal, Udit, Yugang Wang, James Henderson, et al.. (2018). Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature. Molecular Cancer Research. 16(4). 643–654. 27 indexed citations
10.
Jung, Younghun, Frank C. Cackowski, Kenji Yumoto, et al.. (2018). CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Research. 78(8). 2026–2039. 42 indexed citations
11.
Kozminsky, Molly, Shamileh Fouladdel, Jae‐Seung Chung, et al.. (2018). Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate Cancer. Advanced Science. 6(2). 1801254–1801254. 38 indexed citations
12.
Chung, Jae‐Seung, Yugang Wang, Udit Singhal, et al.. (2017). PD71-06 CTC-BASED GENE EXPRESSION FOR PREDICTING RESISTANCE TO ABIRATERONE AND ENZALUTAMIDE IN MCRPC. The Journal of Urology. 197(4S).
13.
Roca, Hernan, Jacqueline Jones, Amy J. Koh, et al.. (2017). Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. Journal of Clinical Investigation. 128(1). 248–266. 103 indexed citations
14.
Hua, Yi, Yugang Wang, & Linxia Gu. (2017). Primary blast waves induced brain dynamics influenced by head orientations. Biomedical Engineering Letters. 7(3). 253–259. 9 indexed citations
15.
Li, Min, Xiaolan Yang, Tao Wen, et al.. (2017). Andrographolide sulfonate reduces mortality in Enterovirus 71 infected mice by modulating immunity. International Immunopharmacology. 55. 142–150. 28 indexed citations
16.
Morgan, Todd M., Jae‐Seung Chung, Yugang Wang, et al.. (2017). Indentification of a CTC-based gene expression signature predicting resistance to abiraterone and enzalutamide in mCRPC.. Journal of Clinical Oncology. 35(15_suppl). 5072–5072.
17.
Wang, Yugang, Ling Xu, Rongrong Jia, et al.. (2016). DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer. Digestive Diseases and Sciences. 61(8). 2272–2283. 27 indexed citations
18.
Qiao, Yuanyuan, Felix Y. Feng, Yugang Wang, et al.. (2016). Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer. Neoplasia. 18(1). 1–9. 18 indexed citations
19.
Wang, Yugang, Wenying Meng, Jiali Ma, et al.. (2014). Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension. International Journal of Molecular Medicine. 33(5). 1131–1139. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingtian Wei Breakdown of academic impact, for papers by Da‐Lei Zhou Breakdown of academic impact, for papers by He-Li Gao Breakdown of academic impact, for papers by Haifeng Wang Breakdown of academic impact, for papers by Yuchao Dong Breakdown of academic impact, for papers by Yixiao Xiong Breakdown of academic impact, for papers by Rongkun Li Breakdown of academic impact, for papers by Xuyu Gu Breakdown of academic impact, for papers by Peifen Fu
Rankless by CCL
2026